These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32444202)

  • 1. Neurometabolic patterns of an "at risk for mental disorders" syndrome involve abnormalities in the thalamus and anterior midcingulate cortex.
    Smesny S; Gussew A; Schack S; Langbein K; Wagner G; Reichenbach JR
    Schizophr Res; 2022 May; 243():285-295. PubMed ID: 32444202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of neurometabolism in the dorsolateral prefrontal cortex and thalamus in transition to psychosis patients change under treatment as usual - A two years follow-up
    Smesny S; Berberich D; Gussew A; Schönfeld N; Langbein K; Walther M; Reichenbach JR
    Schizophr Res; 2021 Feb; 228():7-18. PubMed ID: 33429152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal glutamatergic emotion regulation is disturbed in cluster B and C personality disorders - A combined
    Smesny S; Große J; Gussew A; Langbein K; Schönfeld N; Wagner G; Valente M; Reichenbach JR
    J Affect Disord; 2018 Feb; 227():688-697. PubMed ID: 29174743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
    Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
    Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.
    Liemburg E; Sibeijn-Kuiper A; Bais L; Pijnenborg G; Knegtering H; van der Velde J; Opmeer E; de Vos A; Dlabac-De Lange J; Wunderink L; Aleman A
    Sci Rep; 2016 Feb; 6():21873. PubMed ID: 26903078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
    Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
    Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
    Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
    Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
    Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
    Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between prefrontal N-acetylaspartate and insight in psychotic disorders.
    Larabi DI; Liemburg EJ; Pijnenborg GH; Sibeijn-Kuiper A; de Vos AE; Bais L; Knegtering H; Ćurčić-Blake B; Aleman A
    Schizophr Res; 2017 Jan; 179():112-118. PubMed ID: 27658999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of endurance training and table soccer on brain metabolites in schizophrenia.
    Rauchmann BS; Ghaseminejad F; Keeser D; Keller-Varady K; Schneider-Axmann T; Takahashi S; Karali T; Helms G; Dechent P; Maurus I; Hasan A; Wobrock T; Ertl-Wagner B; Schmitt A; Malchow B; Falkai P
    Brain Imaging Behav; 2020 Apr; 14(2):515-526. PubMed ID: 31686308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of
    Wenneberg C; Glenthøj BY; Hjorthøj C; Buchardt Zingenberg FJ; Glenthøj LB; Rostrup E; Broberg BV; Nordentoft M
    Schizophr Res; 2020 Jan; 215():38-48. PubMed ID: 31784336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamatergic Correlates of Bipolar Symptoms in Adolescents.
    Sonmez AI; Lewis CP; Port JD; Cabello-Arreola A; Blacker CJ; Seewoo BJ; McKean AJ; Leffler JM; Frye MA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):599-605. PubMed ID: 33179961
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
    Burger A; Brooks SJ; Stein DJ; Howells FM
    Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study.
    Frey BN; Stanley JA; Nery FG; Monkul ES; Nicoletti MA; Chen HH; Hatch JP; Caetano SC; Ortiz O; Kapczinski F; Soares JC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():119-27. PubMed ID: 17543030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition.
    Wenneberg C; Nordentoft M; Rostrup E; Glenthøj LB; Bojesen KB; Fagerlund B; Hjorthøj C; Krakauer K; Kristensen TD; Schwartz C; Edden RAE; Broberg BV; Glenthøj BY
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Jun; 5(6):569-579. PubMed ID: 32008981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate and N-Acetylaspartate Alterations Observed in Early Phase Psychosis: A Systematic Review of Proton Magnetic Resonance Spectroscopy Studies.
    Bissonnette JN; Francis AM; MacNeil S; Crocker CE; Tibbo PG; Fisher DJ
    Psychiatry Res Neuroimaging; 2022 Apr; 321():111459. PubMed ID: 35183897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
    Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
    Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
    Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.